momelotinib,danazol
abion pharmaceuticals,biond biologics,sierra oncology,lannett
['simplify', 'momentum', 'momelotinib', 'abion', 'biond ']
congress l #ash22
srdan verstovsek from describes that anemia in mf remains a significant challenge, with recurrent transfusions. momelotinib treatment increases transfusion independence by week 24 (40% vs 19% in other arm), reducing transfusion/treatment burden 
Lifting levels of knowledge in myeloproliferative neoplasms (MPN). A global online platform providing latest treatment options and medical information #mpnsm